Kura Oncology Ownership | Who Owns Kura Oncology?
Kura Oncology Ownership Summary
Kura Oncology is owned by 93.79% institutional investors, 1.15% insiders, and 5.07% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 10.81% of KURA shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 3.10% of its assets in Kura Oncology shares.
KURA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Kura Oncology | 93.79% | 1.15% | 5.07% |
| Sector | Healthcare Stocks | 488.30% | 11.08% | -399.38% |
| Industry | Biotech Stocks | 307.10% | 11.11% | -218.21% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blackrock funding, inc. /de | 9.47M | 10.81% | $54.64M |
| Suvretta capital management | 8.12M | 9.27% | $46.83M |
| Bvf inc/il | 7.75M | 8.85% | $44.74M |
| Blackrock | 6.97M | 8.30% | $143.43M |
| Armistice capital | 6.20M | 7.08% | $35.77M |
| Vanguard group | 4.82M | 5.54% | $41.97M |
| Ecor1 capital | 3.56M | 4.09% | $30.98M |
| Prosight management, lp | 3.18M | 3.63% | $18.36M |
| State street | 2.88M | 3.44% | $59.39M |
| Millennium management | 2.37M | 2.72% | $20.62M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Prosight management, lp | 3.18M | 4.48% | $18.36M |
| Alethea capital management | 558.44K | 4.16% | $4.86M |
| Foresite capital management iv | 816.88K | 3.81% | $4.71M |
| Bvf inc/il | 7.75M | 1.60% | $44.74M |
| Suvretta capital management | 8.12M | 1.41% | $46.83M |
| Sectoral asset management | 323.57K | 1.23% | $1.87M |
| Ecor1 capital | 3.56M | 1.17% | $30.98M |
| 1492 capital management | 423.95K | 1.13% | $2.45M |
| Boxer capital | 1.00M | 1.08% | $20.59M |
| Artal group | 1.82M | 0.96% | $37.47M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Millennium management | 2.37M | 0.01% | 1.52M |
| Blackrock funding, inc. /de | 9.47M | 0.00% | 1.29M |
| Prosight management, lp | 3.18M | 4.48% | 1.10M |
| Qube research | 1.91M | 0.01% | 738.76K |
| D. e. shaw | 1.15M | 0.01% | 727.99K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | - | - | -5.41M |
| Paradigm biocapital advisors lp | - | - | -4.33M |
| Ra capital management | - | - | -4.00M |
| Avoro capital advisors | - | - | -2.25M |
| Ecor1 capital | 3.56M | 1.17% | -2.25M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Sectoral asset management | 323.57K | 1.23% | 323.57K | $1.87M |
| Apis capital advisors | 180.00K | 0.37% | 180.00K | $1.04M |
| Gsa capital partners llp | 89.31K | 0.06% | 89.31K | $778.00K |
| Alps advisors | 46.66K | 0.00% | 46.66K | $269.23K |
| Creative planning | 34.17K | 0.00% | 34.17K | $297.59K |
Sold Out
| Holder | Change |
|---|---|
| National bank of canada /fi/ | -1.00 |
| Ifp advisors | -9.00 |
| Quantbot technologies lp | -14.00 |
| Nelson, van denburg & campbell wealth management group | -14.00 |
| Smartleaf asset management | -17.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 183 | -2.14% | 82,143,917 | 5.53% | 93 | 1.18% | 112 | 16.67% | 43 | -24.56% |
| Mar 31, 2025 | 187 | -1.06% | 80,458,625 | 1.94% | 92 | 1.12% | 97 | -19.83% | 57 | 62.86% |
| Dec 31, 2024 | 104 | -43.48% | 28,722,448 | -65.13% | 33 | 0.37% | 68 | -17.07% | 14 | -75.00% |
| Sep 30, 2024 | 183 | 2.23% | 82,304,529 | 2.31% | 94 | 1.03% | 82 | -2.38% | 56 | -9.68% |
| Jun 30, 2024 | 179 | 4.68% | 80,450,005 | -0.33% | 95 | 1.04% | 84 | -11.58% | 62 | 31.91% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 2.69M | 3.10% | -59.74K |
| Vanguard US Total Market Shares ETF | 2.17M | 2.68% | 3.54K |
| iShares Russell 2000 ETF | 1.89M | 2.17% | - |
| SPDR® S&P Biotech ETF | 1.28M | 1.48% | 2.86K |
| HBM Healthcare Investments AG Ord | 1.21M | 1.40% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 974.31K | 1.12% | -440.17K |
| Invesco MSCI World ETF | 897.58K | 1.03% | 897.58K |
| Fidelity Small Cap Index | 793.04K | 0.91% | 44.84K |
| BlackRock Advantage Small Cap Core Instl | 769.61K | 0.89% | 125.68K |
| iShares Russell 2000 Value ETF | 703.32K | 0.81% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 29, 2025 | Powl Brian T. | Chief Commercial Officer | Sell | $79.51K |
| Sep 29, 2025 | Bair Teresa Brophy | Chief Legal Officer | Sell | $78.74K |
| Sep 29, 2025 | FORD KATHLEEN | Chief Operating Officer | Sell | $61.63K |
| Sep 29, 2025 | Leoni Mollie | Chief Medical Officer | Sell | $110.11K |
| Sep 29, 2025 | WILSON TROY EDWARD | President and CEO | Sell | $327.42K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | 3 | 6 |
| 2025 Q2 | - | 2 |
| 2025 Q1 | - | 15 |
| 2024 Q4 | - | 1 |
| 2024 Q3 | - | - |
KURA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools